RenovoRx, Inc. (RNXT): Submission of Matters to a Vote of Security Holders
RenovoRx, Inc. (RNXT) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 RENOVORX, INC. 2021 OMNIBUS EQUITY INCENTIVE PLAN (as amended on April 16, 2026) Section 1. Purpose of Plan. The name of the Plan is the RenovoRx, Inc. 2021 Omnibus Equity Incentive Plan (the “ Plan ”). The purposes of the Plan are to (i)
How this was made
The 30-second read
Why it matters
Equity incentive plan amendments can influence future share issuance/dilution and therefore valuation multiples, but the excerpt does not provide the key quantitative terms (e.g., total shares authorized, burn rate, or vote results).
Market read
Primarily a governance/compensation-plan update; potential dilution narrative but no concrete new financial/operational catalyst in the provided text.
What to watch
Traders would need the missing proxy/ballot details (e.g., share reserve increase, option/SAR limits, voting results) to judge dilution and any catalyst for re-rating.
Background
The filing is an SEC Form 8-K (Item 5.07) indicating matters were submitted to a vote of security holders, and it includes an exhibit describing the amended 2021 Omnibus Equity Incentive Plan.
Ticker impact
RenovoRx filed an 8-K item 5.07 submitting matters to a vote of security holders, with an amended 2021 equity incentive plan exhibit.
Likely limited, mostly sentiment/dilution narrative unless the vote results or plan share-authorization details are material (not provided here).
The body shows the company’s amended equity incentive plan language and that matters were submitted to a vote; it does not disclose vote outcomes, share counts, or any new operational milestone.
Market effects
Routine equity-plan governance filings are common in biotech/small-cap; sector read-through is minimal without new financing or trial/regulatory updates.
No clear regional macro linkage in the provided text.
No global market linkage indicated.
Counterpoint
The market may already price routine equity-plan amendments; without vote outcomes or share-authorization numbers, the incremental trading signal is likely small.
Key entities
- issuerRenovoRx, Inc.
Subject of the 8-K; amended 2021 Omnibus Equity Incentive Plan submitted to a security-holder vote.
